Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Davis

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Schizophrenia Research|April 17, 2002
Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rateMonte S Buchsbaum, Lina Shihabuddin, Erin A Hazlett, et al.
JAMA|June 5, 2003
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trialPaul S Aisen, Kimberly A Schafer, Michael Grundman, et al.
Neuroreport|September 4, 2008
Temporal characteristics of tract-specific anisotropy abnormalities in schizophreniaDavid M Carpenter, Cheuk Y Tang, Joseph I Friedman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 4, 2005
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathologyMichal Schnaider Beeri, Jeremy M Silverman, Kenneth L Davis, et al.
Biological Psychiatry|August 9, 2006
Diffusion tensor imaging in schizophreniaMonte S Buchsbaum, Joseph Friedman, Bradley R Buchsbaum, et al.
The American Journal of Psychiatry|June 19, 2008
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patientsJoseph I Friedman, Cheuk Tang, David Carpenter, et al.
Schizophrenia Research|June 7, 2011
The effects of hypertension and body mass index on diffusion tensor imaging in schizophreniaCheuk Ying Tang, Joseph I Friedman, David M Carpenter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 25, 2011
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapyJoseph I Friedman, Jean-Pierre Lindenmayer, Frances Alcantara, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophreniaLyudmila Georgieva, Valentina Moskvina, Tim Peirce, et al.
Biological Psychiatry|October 4, 2002
Developing novel treatments for mood disorders: accelerating discoveryCarol A Tamminga, Charles B Nemeroff, Randy D Blakely, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Schizophrenia Research|April 17, 2002
Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rateMonte S Buchsbaum, Lina Shihabuddin, Erin A Hazlett, et al.
JAMA|June 5, 2003
Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trialPaul S Aisen, Kimberly A Schafer, Michael Grundman, et al.
Neuroreport|September 4, 2008
Temporal characteristics of tract-specific anisotropy abnormalities in schizophreniaDavid M Carpenter, Cheuk Y Tang, Joseph I Friedman, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|June 4, 2005
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathologyMichal Schnaider Beeri, Jeremy M Silverman, Kenneth L Davis, et al.
Biological Psychiatry|August 9, 2006
Diffusion tensor imaging in schizophreniaMonte S Buchsbaum, Joseph Friedman, Bradley R Buchsbaum, et al.
The American Journal of Psychiatry|June 19, 2008
Diffusion tensor imaging findings in first-episode and chronic schizophrenia patientsJoseph I Friedman, Cheuk Tang, David Carpenter, et al.
Schizophrenia Research|June 7, 2011
The effects of hypertension and body mass index on diffusion tensor imaging in schizophreniaCheuk Ying Tang, Joseph I Friedman, David M Carpenter, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 25, 2011
Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapyJoseph I Friedman, Jean-Pierre Lindenmayer, Frances Alcantara, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2006
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophreniaLyudmila Georgieva, Valentina Moskvina, Tim Peirce, et al.
Biological Psychiatry|October 4, 2002
Developing novel treatments for mood disorders: accelerating discoveryCarol A Tamminga, Charles B Nemeroff, Randy D Blakely, et al.
Pageof 9